Cencora Inc. has announced a corporate reorganization following a strategic review aimed at aligning its operations with growth priorities and strategic drivers. Effective from the first quarter of fiscal 2026, the company has revised its reporting structure into three segments: U.S. Healthcare Solutions, International Healthcare Solutions, and Other. The U.S. Healthcare Solutions segment will focus on U.S. Human Health, excluding legacy consulting services, while International Healthcare Solutions will encompass Alliance Healthcare, Innomar, World Courier, and key components of Pharmalex. The "Other" category includes businesses such as MWI Animal Health, Profarma, U.S. Consulting Services, and other parts of Pharmalex, for which Cencora is exploring strategic alternatives. The changes were first reported in the company’s quarterly filing for the period ended December 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140859-26-000012), on February 10, 2026, and is solely responsible for the information contained therein.